Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

References

• WisplinghoffHBischoffTTallentSMSeifertHWenzelRPEdmondMBNosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance studyClin Infect Dis200439330931715306996
   PubMed Web of Science ®Google Scholar
• FlevariATheodorakopoulouMVelegrakiAArmaganidisADimopoulosGTreatment of invasive candidiasis in the elderly: a reviewClin Interv Aging201381199120824043935
   PubMed Web of Science ®Google Scholar
• YaparNEpidemiology and risk factors for invasive candidiasisTher Clin Risk Manag2014109510524611015
   PubMed Web of Science ®Google Scholar
• MorrellMFraserVJKollefMHDelaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityAntimicrob Agents Chemother20054993640364516127033
   PubMed Web of Science ®Google Scholar
• TakakuraSFujiharaNSaitoTKudoTIinumaYIchiyamaSNational surveillance of species in Japan and their susceptibility to six antifungal agents including voriconazole and micafunginJ Antimicrob Chemother200453228328914688039
   PubMed Web of Science ®Google Scholar
• ForrestGNWeekesEJohnsonJKIncreasing incidence of Candida parapsilosis candidemia with caspofunin usageJ Infect200856212612918082269
   PubMed Web of Science ®Google Scholar
• TarumotoNAbeYYamaguchiTMaesakiSClinical aspects of candidemia before and after the introduction of micafungin in Saitama Medical School HospitalJpn J Chemother2010581417
   Google Scholar
• AndesDRSafdarNBaddleyJWImpact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trialsClin Infect Dis20125481110112222412055
   PubMed Web of Science ®Google Scholar
• ViscoliCGirmeniaCMarinusACandidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clin Infect Dis19992851071107910452637
   PubMed Web of Science ®Google Scholar
• ColomboALGuimaraesTSukienikTPrognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year periodIntensive Care Med201440101489149825082359
   PubMed Web of Science ®Google Scholar
• ChangRWJacobsSLeeBPredicting outcome among intensive care unit patients using computerized trend analysis of daily Apache II scores corrected for organ system failureIntensive Care Med19881455585663221009
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstituteReference method for dilution antifungal susceptibility testing of yeasts; 4th informational supplement. CLSI document M27-S4Wayne, PAClinical and Laboratory Standards Institute2012
   Google Scholar
• ChenCYHuangSYTangJLClinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001–2010J Antimicrob Chemother201368112632263523766486
   PubMed Web of Science ®Google Scholar
• PfallerMADiekemaDJProgress in antifungal susceptibility testing of Candida spp. By use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012J Clin Microbiol20125092846285622740712
   PubMed Web of Science ®Google Scholar
• NagaoMSaitoTDoiSClinical characteristics and risk factors of ocular candidiasisDiagn Microbial Infect Dis2012732149152
   PubMed Web of Science ®Google Scholar
• PappasPGKauffmanCAAndesDClinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaClin Infect Dis200948550353519191635
   PubMed Web of Science ®Google Scholar
• TakakuraSFujiharaNSaitoTClinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infectionEur J Cliln Microbiol Infect Dis2004235380388
   Web of Science ®Google Scholar
• KollefMMicekSHamptonNDohertyJAKumarASeptic shock attributed to Candida infection: importance of empiric therapy and source controlClin Infect Dis201254121739174622423135
   PubMed Web of Science ®Google Scholar
• WangHLiuNYinMThe epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicenter retrospective studyBMC Infect Dis20141460925420435
   PubMed Web of Science ®Google Scholar
• PfallerMADiekemaDJJonesRNMesserSAHollisRJSENTRY Participants GroupTrends in antifungal susceptibility of Candida spp. Isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000J Clin Microbiol200240385285611880404
   PubMed Web of Science ®Google Scholar
• Al-RawahiGNRoscoeDLTen-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida speciesCan J Infect Dis Med Microbiol2013243e65e6824421833
   PubMed Web of Science ®Google Scholar
• PlayfordEGMarriottDNguyenQCandidemia in nonneutropenic ill patients: risk factors for non-albicans Candida sppCrit Care Med20083672034203918552700
   PubMed Web of Science ®Google Scholar
• AnaissieEJRexJHUzunOVartivarianSPredictors of adverse outcome in cancer patients with candidemiaAm J Med199810432382459552086
   PubMed Web of Science ®Google Scholar
• ViudesAPemánJCantónEUbedaPLópez-RibotJLGobernadoMCandidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for deathEur J Clin Microbiol Infect Dis2002211176777412461585
   PubMed Web of Science ®Google Scholar
• ChenYRLinLCYoungTGLiuCEChenCHTsayRWRisk factors for candidemia-related mortality at a medical center in central TaiwanJ Microbiol Immunol Infect200639215516116604249
   PubMedGoogle Scholar